Discovery of GPR183 Agonists Based on an Antagonist Scaffold-Reference-Cited by-同舟云学术

Discovery of GPR183 Agonists Based on an Antagonist Scaffold

Published:2021-08-03 Issue:17 Volume:16 Page:2623-2627
ISSN:1860-7179
Container-title:ChemMedChem
language:en
Short-container-title:ChemMedChem

Author:

Kjær Viktoria M. S.¹,Ieremias Loukas²,Daugvilaite Viktorija¹,Lückmann Michael³,Frimurer Thomas M.³,Ulven Trond²,Rosenkilde Mette M.¹,Våbenø Jon⁴^ORCID

Affiliation:

1. Department of Biomedical Sciences Faculty of Health and Medical Sciences University of Copenhagen Blegdamsvej 3B 2200 Copenhagen Denmark

2. Department of Drug Design and Pharmacology Faculty of Health and Medical Sciences University of Copenhagen Jagtvej 162 2100 Copenhagen Denmark

3. Novo Nordisk Foundation Center for Basic Metabolic Research University of Copenhagen Maersk Tower Blegdamsvej 3B 2200 Copenhagen Denmark

4. Helgeland Hospital Trust Prestmarkveien 1 8800 Sandnessjøen Norway

Publisher

Wiley

Subject

Organic Chemistry,General Pharmacology, Toxicology and Pharmaceutics,Molecular Medicine,Drug Discovery,Biochemistry,Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cmdc.202100301

Reference19 articles.

1. Epstein-Barr virus-induced genes: first lymphocyte-specific G protein-coupled peptide receptors

3. Molecular Pharmacological Phenotyping of EBI2

4. Ligand Modulation of the Epstein-Barr Virus-induced Seven-transmembrane Receptor EBI2

5. Small molecule antagonism of oxysterol-induced Epstein-Barr virus induced gene 2 (EBI2) activation

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Progress on the development of Class A GPCR‐biased ligands;British Journal of Pharmacology;2024-09-11

2. Application of FRET- and BRET-based live-cell biosensors in deorphanization and ligand discovery studies on orphan G protein-coupled receptors;SLAS Discovery;2024-09

3. Relevance of G protein‐coupled receptor (GPCR) dynamics for receptor activation, signalling bias and allosteric modulation;British Journal of Pharmacology;2024-07-08

4. Discovery of a First-in-Class GPR183 Antagonist for the Potential Treatment of Rheumatoid Arthritis;Journal of Medicinal Chemistry;2023-12-04

5. Ligand entry pathways control the chemical space recognized by GPR183;CHEM SCI;2023